LLY Stock Recent News
LLY LATEST HEADLINES
Eli Lilly's (LLY, Financial) stock experienced a notable movement, rising 1.71% to a price of $913.72. This surge was driven by the Congressional Budget Office (CBO) report on the potential impact if Medicare were to cover anti-obesity medications, including Eli Lilly's weight loss drug, Zepbound.
Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly's blockbuster weight loss and diabetes drugs from its shortage list last week, a move expected to curtail compounding facilities' ability to sell their own versions of the drugs.
One of these businesses is a risky play, but the other is very likely to succeed.
Clinical studies highlight that Eli Lilly (LLY, Financial) and Novo Nordisk's (NVO) weight loss drugs result in significant lean body mass reduction, with 25% and 40% of weight loss attributed to muscle loss, respectively. In response, Regeneron (REGN) is researching a new drug aimed at mitigating muscle loss caused by weight loss medications.
Lee Brown with Third Bridge argues that demanding expectations are built into Eli Lilly's (LLY) stock following a "monstrous" 2Q earnings report. Mounjaro and Zepbound no longer on short supply helps the outlook, but Lee looks into other headwinds facing the pharmaceutical company, including the ILA Union's port worker strike.
The Investment Committee debate the latest Calls of The Day.
Here is how Eli Lilly (LLY) and BioLife Solutions, Inc. (BLFS) have performed compared to their sector so far this year.
England's National Health Services plans to offer Eli Lilly's weight-loss drugs to nearly a quarter million people as part of a three-year plan, UK's drugs cost regulator said on Thursday.
The U.S. Food and Drug Administration said Eli Lilly's diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage signaling that the company has succeeded in expanding manufacturing.